V. Nooney

Clopidogrel "resistance": pre- vs post-receptor determinants.

R. de Caterina, J. Horowitz, R. Caterina, 2013, Vascular pharmacology.

Subtle renal dysfunction and bleeding risk in atrial fibrillation: symmetric dimethylarginine predicts HAS-BLED score.

S. Stewart, J. Ball, J. Horowitz, 2015, American journal of cardiovascular disease.

Impaired adenylate cyclase signaling in acute myocardial ischemia: Impact on effectiveness of P2Y12 receptor antagonists.

R. de Caterina, J. Horowitz, T. H. Nguyen, 2019, Thrombosis research.

Post receptor determinants of acute platelet response to clopidogrel in patients with symptomatic myocardial ischemia.

R. de Caterina, J. Horowitz, N. Hurst, 2015, Vascular pharmacology.

Determinants of subacute response to clopidogrel: relative impact of CYP2C19 genotype and PGE1/adenylate cyclase signalling.

R. de Caterina, J. Horowitz, N. Hurst, 2015, Thrombosis research.

New Developments in Platelet Cyclic Nucleotide Signalling: Therapeutic Implications

J. Horowitz, R. Caterina, H. Imam, 2016, Cardiovascular Drugs and Therapy.

Feasibility and Timeliness of Alternatives to Post‐Discharge Home Medicines Reviews for High‐Risk Patients

M. Angley, S. Shakib, V. Nooney, 2011 .

Impaired platelet nitric oxide response in patients with new onset atrial fibrillation.

S. Stewart, M. Carrington, E. Hylek, 2015, International journal of cardiology.